Market openNon-fractional

Pharvaris/PHVS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Pharvaris

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

Ticker

PHVS

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Leiden, Netherlands

Employees

83

Pharvaris Metrics

BasicAdvanced
$991M
Market cap
-
P/E ratio
-$2.65
EPS
-3.10
Beta
-
Dividend rate
$991M
-3.1
20.526
20.112
0.019
0.053
-24.78%
-43.52%
2.54
2.54
-7.385
-0.29%
-20.42%

What the Analysts think about Pharvaris

Analyst Ratings

Majority rating from 7 analysts.
Buy

Pharvaris Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
€0
NaN%
Net income
-€28M
-14.37%
Profit margin
0.00%
NaN%

Pharvaris Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.67%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-€0.63
-€0.58
-€0.76
-€0.52
-
Expected
-€0.65
-€0.60
-€0.53
-€0.56
-€0.55
Surprise
-3.06%
-4.11%
42.59%
-7.67%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Pharvaris stock?

Pharvaris (PHVS) has a market cap of $991M as of July 05, 2024.

What is the P/E ratio for Pharvaris stock?

The price to earnings (P/E) ratio for Pharvaris (PHVS) stock is 0 as of July 05, 2024.

Does Pharvaris stock pay dividends?

No, Pharvaris (PHVS) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Pharvaris dividend payment date?

Pharvaris (PHVS) stock does not pay dividends to its shareholders.

What is the beta indicator for Pharvaris?

Pharvaris (PHVS) has a beta rating of -3.1. This means that it has an inverse relation to market volatility.

Buy or sell Pharvaris stock

Buy or sell Pharvaris stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing